It is not known whether conservative or early aggressive (resective surgery with or without radiotherapy) management is better for tumours presenting with epilepsy.
Controversy exists regarding the management of intrinsic brain tumours. ' Neurologists believe that resective surgery and radiotherapy are essentially palliative and carry some risks. 2 They accept that radiotherapy prolongs survival in malignant gliomas"' but feel that quality of life may be poor67 and that evidence for the benefit of resective surgery is unconvincing and derived from work on selected populations.89 Neurosurgeons are more positive about the benefits of radiotherapy and extensive surgical resection in both high"1'3 and low-grade tumours."4 They express the concern that conservative management may lead to misdiagnosis and delayed treatment of potentially curable conditions. The clinical dilemma is greatest for less malignant tumours. Neurologists often investigate patients with epilepsy and find low density mass lesions on a CT scan. They manage such patients conservatively by treating their seizures and clinical experience suggests that many patients will survive for years with epilepsy as their only symptom.
Information, derived from surgical series, has suggested that patients presenting with epilepsy have a relatively good prognosis3 1617 and this may be irrespective of tumour grade.'7 Several recent studies have demonstrated that, in patients with intrinsic supratentorial tumours, the most important clinical predictors of outcome are age5 1819 and performance status at presentation.' 16 2 Tumour grade has been shown to be an important prognostic factor in some series'92' but not in others. 3 14 The widespread and increasing availability of sensitive neuro-imaging techniques (CT and MRI) means that patients with a short history of epilepsy are more likely to be scanned. A proportion of these will be shown to have "lesions" which are probably gliomas. This is therefore an increasingly common management problem for both neurologists and neurosurgeons and neither group knows whether the optimal management approach is early surgery and radiotherapy or a conservative policy of symptomatic treatment until other problems develop.
A retrospective analysis of the prognosis of patients with a diagnosis, on clinical and CT grounds, of primary intrinsic supratentorial tumour has been conducted. The group presenting with epilepsy were subdivided into those who had early surgery (within two months of CT diagnosis) and the rest. This latter group included patients who had surgery at a later date and patients not operated on at any time. The reason for this division was to avoid unfair bias against surgical treatment as in some patients the initial decision was to treat conservatively but this was reconsidered after neurological deterioration. These two groups (early surgery, no early surgery) were compared for clinical and CT features at presentation and outcome.
Methods
Confidence intervals for odds ratios were calculated using Confidence Intervals Analysis. 22 Initial comparison of the survival of the two groups used the Kaplan-Meier product limit estimate. Cox's proportional hazards model23 was used to investigate the effect of covariates on survival. The covariates are the main symptoms at presentation, results from CT scans and treatment variables. As there were 93 deaths in the group presenting with epilepsy and 372 in the group presenting with other symptoms, it was reasonable to consider several explanatory variables.
Results

A) Comparison ofpatients presenting with
epilepsy and those presenting with other symptoms A total of 560 patients were identified of whom 164 had epilepsy as their first symptom and 396 presented with other symptoms.
The group presenting with epilepsy was younger (mean age 45 years, range six to 76 years) with a preponderance of males (M:F = 109:55). Patients with other presentations were older (mean age 55 years, range six to 80 years) with a more even sex distribution (M:F = 219:177). Average duration of symptoms before CT diagnosis was 28 months (range two days-232 months) in those presenting with epilepsy and four months (range one day-175 months) in those with other presentations.
In those presenting with epilepsy seizures were refractory to anti-epileptic drugs with only 11/164 patients ever achieving a one year remission. EEG was performed at diagnosis in 102/164 patients. This showed no abnormality in nine, non-specific abnormality in 13, focal spikes in six, focal spike and slow wave in six and focal slow wave abnormalities only in 68.
One hundred and seven of one hundred and sixty four patients (65%) presenting with epilepsy and 284/396 (71 %) with other presentations had some form of surgery with resective surgery being performed in 32 (20%) and 43 (11%) cases respectively. Eighty six (52%) of those presenting with epilepsy and 250 (63%) of the rest had radiotherapy. The diagnosis of glioma was histologically confirmed in 100 (61%) patients presenting with epilepsy and 256 (65%) of the other group.
In the group presenting with epilepsy 80 patients had "early" surgery (within two months of CT diagnosis), 27 had "delayed" surgery (more than two months after CT diagnosis) and 57 had no surgery.
Odds ratios were used to determine whether there were any significant differences between the two groups (epilepsy as first symptom and other presentations). seizures. The risks, however, both short and long-term, of surgery and radiotherapy in neurologically intact patients may not be justified if such treatments do not favourably influence the natural history of these lesions.
Our findings support the widely held clinical impression that epilepsy may, for many years, be the only manifestation of intracerebral tumours which behave in a relatively benign manner. Epilepsy as a first symptom appears to be one of the most important ways of identifying tumours with good quality survival. In some studies" 1 epilepsy has been found to be a favourable prognostic factor only on univariate analysis, being displaced on multivariate analysis by duration of symptoms before diagnosis." However, these studies have considered only histologically proven malignant gliomas and the number of patients presenting with epilepsy was relatively small. Other workers have found epilepsy as a presenting symptom'7 and length of history of fits'3 to be significant independent variables favourably influencing survival.
We have confirmed, in agreement with other studies, the importance of age5"8'9 and the presence of other symptoms and signs '6 1920 28 The results derived from this study could be criticised on the basis that only 60-70% of lesions are histologically proven imours. More specifically, of the 84 patients in the "no early surgery" group 57 were managed conservatively (that is, no histology obtained) and 27 had delayed surgery. In the latter group the initial decision was to treat conservatively but surgery was subsequently performed and a tumour was confirmed histologically in every case. It could be argued that a significant proportion of those patients, in whom the diagnosis was made on clinical and CT grounds only, did not have gliomas. Of these 57 patients nine have died and 29 others have shown either clinical deterioration, radiological progression of the lesion or both. The diagnosis therefore is dependent on the appearances of the lesion on a single CT scan in only 19 patients. Previous research has demonstrated that a lesion diagnosed as malignant on a single CT scan is subsequently shown to be benign in 1 228-10%29 of cases. Even if this latter figure is applied to our group we feel that there is reasonable doubt about the diagnosis of a tumour in very few cases and that diagnostic error would not explain the observed differences between the groups.
There is good evidence from prospective studies showing the value of post-operative radiotherapy in prolonging survival in malignant glioma. 
